Teladoc Health (NYSE:TDOC) Issues FY24 Earnings Guidance

Teladoc Health (NYSE:TDOC) issued an update on its FY24 earnings guidance on Thursday morning. The company provided EPS guidance of ($1.10)-($0.80) for the period, compared to the consensus EPS estimate of ($1.03). The company issued revenue guidance of $2.635-$2.735 billion, compared to the consensus revenue estimate of $2.66 billion. Teladoc Health also updated its Q2 guidance to ($0.45)-($0.35) EPS.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the company. TD Cowen cut their price objective on Teladoc Health from $16.00 to $15.00 and set a hold rating for the company in a research report on Friday. DA Davidson cut their price objective on Teladoc Health from $22.00 to $18.00 and set a neutral rating for the company in a research report on Wednesday, February 21st. Needham & Company LLC restated a hold rating on shares of Teladoc Health in a research report on Friday. Barclays cut their price objective on Teladoc Health from $25.00 to $20.00 and set an overweight rating for the company in a research report on Friday. Finally, SVB Leerink started coverage on Teladoc Health in a research report on Monday, February 26th. They issued a market perform rating and a $17.00 price objective for the company. Eleven analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of Hold and a consensus price target of $19.67.

Teladoc Health Stock Down 2.4 %

NYSE TDOC traded down $0.32 on Friday, reaching $13.01. 7,696,741 shares of the company were exchanged, compared to its average volume of 4,813,149. The business’s fifty day moving average price is $15.01 and its 200 day moving average price is $17.77. The company has a debt-to-equity ratio of 0.66, a quick ratio of 3.47 and a current ratio of 3.54. Teladoc Health has a fifty-two week low of $12.65 and a fifty-two week high of $30.41.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Thursday, April 25th. The health services provider reported ($0.49) EPS for the quarter, missing the consensus estimate of ($0.47) by ($0.02). Teladoc Health had a negative net margin of 8.90% and a negative return on equity of 10.11%. The business had revenue of $646.13 million during the quarter, compared to analyst estimates of $637.31 million. During the same period last year, the company earned ($0.37) EPS. The business’s revenue for the quarter was up 2.7% on a year-over-year basis. Equities analysts expect that Teladoc Health will post -1.07 earnings per share for the current fiscal year.

Insider Activity

In other news, insider Laizer Kornwasser sold 7,882 shares of the company’s stock in a transaction on Friday, February 2nd. The stock was sold at an average price of $19.18, for a total value of $151,176.76. Following the transaction, the insider now owns 57,223 shares of the company’s stock, valued at approximately $1,097,537.14. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In related news, insider Laizer Kornwasser sold 7,882 shares of the business’s stock in a transaction on Friday, February 2nd. The stock was sold at an average price of $19.18, for a total value of $151,176.76. Following the sale, the insider now owns 57,223 shares in the company, valued at approximately $1,097,537.14. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, COO Michael Willem Waters sold 4,523 shares of the business’s stock in a transaction on Friday, February 2nd. The shares were sold at an average price of $19.18, for a total value of $86,751.14. Following the completion of the sale, the chief operating officer now owns 38,570 shares in the company, valued at approximately $739,772.60. The disclosure for this sale can be found here. Insiders have sold a total of 135,441 shares of company stock valued at $2,038,251 in the last quarter. Insiders own 1.63% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.